» Articles » PMID: 29296360

Predictability and Uncertainty in Arteriovenous Malformation Radiosurgery

Overview
Date 2018 Jan 4
PMID 29296360
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Stereotactic radiosurgery (SRS) is an accepted management option for patients with cerebral arteriovenous malformations (AVM). The need for a system that accurately predicts patient outcomes after AVM SRS led to the development of the radiosurgery-based AVM score (RBAS). The original RBAS was simplified and been validated by numerous centers performing Gamma Knife, LINAC-based, and CyberKnife procedures. It is clear that no predictive method can be perfect due to the uncertainty that is inherent to complex, biologic systems.

Citing Articles

Stereotactic Radiotherapy for Intramedullary Spinal Arteriovenous Malformations.

Mori Y, Hashizume C, Tsugawa T, Kato S, Shibamoto Y Cureus. 2018; 10(7):e2908.

PMID: 30186713 PMC: 6122653. DOI: 10.7759/cureus.2908.

References
1.
Karlsson B, Lax I, Soderman M . Risk for hemorrhage during the 2-year latency period following gamma knife radiosurgery for arteriovenous malformations. Int J Radiat Oncol Biol Phys. 2001; 49(4):1045-51. DOI: 10.1016/s0360-3016(00)01432-2. View

2.
Pollock B, Flickinger J . A proposed radiosurgery-based grading system for arteriovenous malformations. J Neurosurg. 2002; 96(1):79-85. DOI: 10.3171/jns.2002.96.1.0079. View

3.
Tos M, Stangerup S, Caye-Thomasen P, Tos T, Thomsen J . What is the real incidence of vestibular schwannoma?. Arch Otolaryngol Head Neck Surg. 2004; 130(2):216-20. DOI: 10.1001/archotol.130.2.216. View

4.
Zipfel G, Bradshaw P, Bova F, Friedman W . Do the morphological characteristics of arteriovenous malformations affect the results of radiosurgery?. J Neurosurg. 2004; 101(3):393-401. DOI: 10.3171/jns.2004.101.3.0393. View

5.
Souhami L, Seiferheld W, Brachman D, Podgorsak E, Werner-Wasik M, Lustig R . Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys. 2004; 60(3):853-60. DOI: 10.1016/j.ijrobp.2004.04.011. View